Gemcitabine treatment compared with bladder wash in UTUC surgery
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This Phase 3 trial studies whether using gemcitabine (a chemotherapy medicine) in the urinary tract better prevents cancer from coming back than using a simple water wash. It involves people with upper tract urothelial carcinoma who are having curative surgery to remove the affected ureter or kidney tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have biopsy-proven upper tract urothelial cancer and are planning curative surgery to remove part of the ureter or kidney tube
- You are between 18 and 90 years old
- Your expected lifespan is more than 1 year
- You can and will sign written informed consent
- If you could become pregnant, you can use reliable birth control during the study and for 90 days after treatment ends
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting gemcitabine into the bladder lining during tumor removal surgery can help prevent the cancer from coming back in people with intermediate- or high-risk non-muscle-invasive bladder cancer.
This trial tests a combination of two chemotherapy drugs, gemcitabine and mitomycin, given directly into the kidney or ureter through a thin tube. It is for people with a high-risk but non-invasive form of upper urinary tract cancer that has not spread into deeper tissues.
This trial tests using chemotherapy directly into the bladder to treat low-grade bladder cancer that has come back, as an alternative to surgery. It may help people with small, low-grade tumors avoid the need for a more invasive procedure.
This trial tests whether giving chemotherapy before surgery can help people with high-risk upper tract urothelial cancer (a cancer in the kidney or ureter). The goal is to see if it improves outcomes for those who are healthy enough to receive cisplatin-based chemotherapy and undergo surgery.
This trial tests whether putting chemotherapy medicine directly into the bladder right after surgery helps prevent bladder cancer from coming back. It compares gemcitabine versus epirubicin given as an immediate bladder “wash-in.”
This study is testing whether giving a single dose of chemotherapy directly into the kidney and ureter right after a scope procedure helps prevent upper urinary tract tumors from coming back. It’s for people who are about to have a scope to diagnose or treat a suspected or known tumor in the upper urinary tract.
Hear when a new Urothelial Cancer of Renal Pelvis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.